Clinical Trial: Study of XPF-001 in the Treatment of Pain From Primary/Inherited Erythromelalgia (IEM)
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Phase 2a, Double-blind, Placebo-controlled, 2-period, Crossover Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Multiple Oral Doses of XPF-001 in Patients With Inherited Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Xenon Pharmaceuticals Inc.
Dates:
Date Received: March 17, 2010
Date Started: April 2010
Date Completion:
Last Updated: March 14, 2012
Last Verified: March 2012